Tropisetron (Navoban (R)) in the control of nausea and vomiting induced by combined cancer chemotherapy in children

Abstract

Background: We aimed to assess the potency and efficacy of tropisetron, a 5-HT3 receptor antagonist, in the prevention of nausea and emesis observed in the pediatric patient population taking various chemotherapy protocols.